Salesforce shares jump as investors reassess recent earnings and massive buyback support

Salesforce (CRM) is up 7.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks most consistent with a post-earnings rebound as investors refocus on profitability and shareholder returns after an initially cautious reaction to the company’s latest outlook. The scale and execution of Salesforce’s accelerated share repurchase program may also be supporting sentiment and prompting short-covering.

Details:

Salesforce’s most recent quarterly update showed results that beat expectations on profit, but near-term revenue outlook commentary was viewed as conservative, weighing on shares immediately after the report.

The company has been executing a very large accelerated share repurchase program, including an initial delivery of roughly 103 million shares tied to $25 billion ASR agreements.

Management highlighted substantial capital return in the quarter (including tens of billions of dollars of repurchases), which can improve per-share metrics and provide a valuation “floor” when the stock is under pressure.

This could also be a technical bounce after a sharp selloff around the earnings release, with broader software sentiment stabilizing.

Sources:

Salesforce Investor Relations, Business Wire, Axios

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRM Insider Trading Activity

$CRM insiders have traded $CRM stock on the open market 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:

PARKER HARRIS (Co-Founder and CTO, Slack) has made 0 purchases and 5 sales selling 134,662 shares for an estimated $31,605,031.
G MASON MORFIT purchased 96,000 shares for an estimated $25,015,680
DAVID BLAIR KIRK has made 2 purchases buying 4,506 shares for an estimated $1,000,900 and 0 sales.
NEELIE KROES sold 3,893 shares for an estimated $929,275
LAURA ALBER has made 2 purchases buying 2,571 shares for an estimated $500,266 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CRM Hedge Fund Activity

We have seen 1,263 institutional investors add shares of $CRM stock to their portfolio, and 1,764 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP removed 47,202,137 shares (-99.6%) from their portfolio in Q1 2026, for an estimated $8,797,534,294
MORGAN STANLEY added 12,666,457 shares (+66.6%) to their portfolio in Q1 2026, for an estimated $2,360,774,255
CAPITAL INTERNATIONAL INVESTORS removed 10,096,552 shares (-44.4%) from their portfolio in Q1 2026, for an estimated $1,881,795,361
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 7,160,302 shares (+130.2%) to their portfolio in Q1 2026, for an estimated $1,334,537,086
JPMORGAN CHASE & CO removed 6,496,920 shares (-49.8%) from their portfolio in Q4 2025, for an estimated $1,721,099,077
HARRIS ASSOCIATES L P added 5,126,665 shares (+52.4%) to their portfolio in Q1 2026, for an estimated $955,507,822
CAPITAL RESEARCH GLOBAL INVESTORS added 4,237,753 shares (+44.8%) to their portfolio in Q1 2026, for an estimated $789,832,404

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRM Congressional Stock Trading

Members of Congress have traded $CRM stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:

REPRESENTATIVE MARIA ELVIRA SALAZAR purchased up to $50,000 on 04/06.
REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 2 purchases worth up to $30,000 on 02/09, 01/29 and 2 sales worth up to $65,000 on 02/26.
REPRESENTATIVE JULIA LETLOW has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/02, 12/16.
SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CRM Analyst Ratings

Wall Street analysts have issued reports on $CRM in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 02/26/2026
BTIG issued a "Buy" rating on 12/17/2025
Needham issued a "Buy" rating on 12/04/2025
BMO Capital issued a "Outperform" rating on 12/04/2025
Wedbush issued a "Outperform" rating on 12/04/2025
Baird issued a "Outperform" rating on 12/04/2025
Citizens issued a "Market Outperform" rating on 12/04/2025

To track analyst ratings and price targets for $CRM, check out Quiver Quantitative's $CRM forecast page.

$CRM Price Targets

Multiple analysts have issued price targets for $CRM recently. We have seen 33 analysts offer price targets for $CRM in the last 6 months, with a median target of $250.0.

Here are some recent targets:

Tyler Radke from Citigroup set a target price of $187.0 on 05/28/2026
Billy Fitzsimmons from Piper Sandler set a target price of $215.0 on 05/28/2026
Mark Moerdler from Bernstein set a target price of $173.0 on 05/28/2026
David Hynes from Canaccord Genuity set a target price of $225.0 on 05/28/2026
Patrick Walravens from Citizens set a target price of $315.0 on 05/28/2026
Michael Turrin from Wells Fargo set a target price of $200.0 on 05/28/2026
Raimo Lenschow from Barclays set a target price of $236.0 on 05/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.